Literature DB >> 30099215

Electrospun fixed dose formulations of amlodipine besylate and valsartan.

Haitham Bukhary1, Gareth R Williams2, Mine Orlu3.   

Abstract

Increasing numbers of elderly people require multi-drug therapies. One route to improve adherence rates is to prepare fixed dose combinations (FDCs), in which multiple active ingredients are loaded into a single formulation. Here, we report the use of electrospinning to prepare fast-dissolving oral FDCs containing amlodipine besylate and valsartan, two drugs prescribed as FDCs for the treatment of hypertension. Electrospun fibers were prepared loaded with one or both drugs, using polyvinylpyrrolidone as the polymer matrix. The fibers were largely cylindrical in morphology and comprise amorphous solid dispersions except with the highest loadings of amlodipine besylate. HPLC demonstrated drug entrapment efficiencies of >85% of the theoretical dose. The mats have folding endurances and thicknesses suitable for use as oral films. The amlodipine besylate-loaded systems are fast-dissolving, with >90% release obtained within 120 s. In contrast, valsartan release from its single-drug formulations took longer, ranging from 360 s to 24 min. With the FDC formulations, rapid release within 360 s was achieved when the loading was 5% w/w of each drug, but again the release time increased with drug loading. Electrospun fibers therefore have significant promise as FDCs, but the target drug and its loading need to be carefully considered.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amlodipine besylate; Electrospinning; Fast dissolving films; Fixed dose combinations; Polyvinylpyrrolidone; Valsartan

Mesh:

Substances:

Year:  2018        PMID: 30099215     DOI: 10.1016/j.ijpharm.2018.08.008

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Biocompatibility studies of polyurethane electrospun membranes based on arginine as chain extender.

Authors:  Georgina Alejandra Venegas-Cervera; Andrés Iván Oliva; Alejandro Avila-Ortega; José Manuel Cervantes-Uc; Leydi Maribel Carrillo-Cocom; Juan Antonio Juarez-Moreno
Journal:  J Mater Sci Mater Med       Date:  2021-08-20       Impact factor: 3.896

2.  Fast-Dissolving Nifedipine and Atorvastatin Calcium Electrospun Nanofibers as a Potential Buccal Delivery System.

Authors:  Hassa A Alshaya; Ahmed J Alfahad; Fatemah M Alsulaihem; Alhassan H Aodah; Abdullah A Alshehri; Fahad A Almughem; Haya A Alfassam; Ahmad M Aldossary; Abdulrahman A Halwani; Haitham A Bukhary; Moutaz Y Badr; Salam Massadeh; Manal Alaamery; Essam A Tawfik
Journal:  Pharmaceutics       Date:  2022-02-04       Impact factor: 6.321

3.  Melittin from Bee Venom Encapsulating Electrospun Fibers as a Potential Antimicrobial Wound Dressing Patches for Skin Infections.

Authors:  Walaa S Aburayan; Areej M Alajmi; Ahmed J Alfahad; Wijdan K Alsharif; Abdullah A Alshehri; Rayan Y Booq; Samar A Alsudir; Fatemah M Alsulaihem; Haitham A Bukhary; Moutaz Y Badr; Essam J Alyamani; Essam A Tawfik
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

Review 4.  Electrospun fibers and their application in drug controlled release, biological dressings, tissue repair, and enzyme immobilization.

Authors:  Yue Sun; Shihong Cheng; Wenjuan Lu; Yanfeng Wang; Pingping Zhang; Qingqiang Yao
Journal:  RSC Adv       Date:  2019-08-15       Impact factor: 4.036

5.  Comparison of Nozzle-Based and Nozzle-Free Electrospinning for Preparation of Fast-Dissolving Nanofibers Loaded with Ciprofloxacin.

Authors:  Luca Éva Uhljar; Areen Alshweiat; Gábor Katona; Michael Chung; Norbert Radacsi; Dávid Kókai; Katalin Burián; Rita Ambrus
Journal:  Pharmaceutics       Date:  2022-07-27       Impact factor: 6.525

6.  Hydrocortisone/cyclodextrin complex electrospun nanofibers for a fast-dissolving oral drug delivery system.

Authors:  Asli Celebioglu; Tamer Uyar
Journal:  RSC Med Chem       Date:  2020-01-08

7.  Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder.

Authors:  Manal E Alkahtani; Alhassan H Aodah; Omar A Abu Asab; Abdul W Basit; Mine Orlu; Essam A Tawfik
Journal:  Pharmaceutics       Date:  2021-06-16       Impact factor: 6.321

8.  Improved Release of a Drug with Poor Water Solubility by Using Electrospun Water-Soluble Polymers as Carriers.

Authors:  Muriel Józó; Nóra Simon; Lan Yi; János Móczó; Béla Pukánszky
Journal:  Pharmaceutics       Date:  2021-12-24       Impact factor: 6.321

9.  Nanostructured Valsartan Microparticles with Enhanced Bioavailability Produced by High-Throughput Electrohydrodynamic Room-Temperature Atomization.

Authors:  Cristina Prieto; Zoran Evtoski; María Pardo-Figuerez; Julia Hrakovsky; Jose M Lagaron
Journal:  Mol Pharm       Date:  2021-06-28       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.